Medicover AB Series B
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Servi… Read more
Market Cap & Net Worth: Medicover AB Series B (0RPS)
Medicover AB Series B (LSE:0RPS) has a market capitalization of $2.40 Billion (Skr26.93 Billion) as of March 18, 2026. Listed on the LSE stock exchange, this UK-based company holds position #7695 globally and #204 in its home market, demonstrating a -3.58% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medicover AB Series B's stock price Skr202.00 by its total outstanding shares 133335000 (133.34 Million).
Medicover AB Series B Market Cap History: 2017 to 2026
Medicover AB Series B's market capitalization history from 2017 to 2026. Data shows growth from $731.04 Million to $2.40 Billion (14.02% CAGR).
Medicover AB Series B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medicover AB Series B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.09x
Medicover AB Series B's market cap is 1.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
136.65x
Medicover AB Series B's market cap is 136.65 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $731.04 Million | $580.20 Million | $18.70 Million | 1.26x | 39.09x |
| 2018 | $844.88 Million | $671.60 Million | $24.60 Million | 1.26x | 34.34x |
| 2019 | $1.23 Billion | $844.40 Million | $22.50 Million | 1.45x | 54.55x |
| 2020 | $1.90 Billion | $997.80 Million | $25.80 Million | 1.90x | 73.47x |
| 2021 | $4.27 Billion | $1.38 Billion | $101.80 Million | 3.10x | 41.95x |
| 2022 | $1.64 Billion | $1.51 Billion | $11.80 Million | 1.08x | 138.76x |
| 2023 | $1.77 Billion | $1.75 Billion | $17.60 Million | 1.01x | 100.66x |
| 2024 | $2.28 Billion | $2.09 Billion | $16.70 Million | 1.09x | 136.65x |
Competitor Companies of 0RPS by Market Capitalization
Companies near Medicover AB Series B in the global market cap rankings as of March 18, 2026.
Key companies related to Medicover AB Series B by market ranking:
- Beijing Fuxing Xiaocheng Electronic Technology Co Ltd (SHE:300139): Ranked #7686 globally with a market cap of $918.28 Million USD ( CN¥6.74 Billion CNY).
- Predictive Discovery Ltd (AU:PDI): Ranked #7687 globally with a market cap of $918.22 Million USD ( AU$1.48 Billion AUD).
- Client Service International Inc (SHE:300663): Ranked #7696 globally with a market cap of $915.93 Million USD ( CN¥6.72 Billion CNY).
- Medicover AB (publ) (PINK:MCVEF): Ranked #7697 globally with a market cap of $915.67 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #7686 | Beijing Fuxing Xiaocheng Electronic Technology Co Ltd | SHE:300139 | $918.28 Million | CN¥63.26 |
| #7687 | Predictive Discovery Ltd | AU:PDI | $918.22 Million | AU$0.85 |
| #7696 | Client Service International Inc | SHE:300663 | $915.93 Million | CN¥15.63 |
| #7697 | Medicover AB (publ) | PINK:MCVEF | $915.67 Million | $18.00 |
Medicover AB Series B Historical Marketcap From 2017 to 2026
Between 2017 and today, Medicover AB Series B's market cap moved from $731.04 Million to $ 2.40 Billion, with a yearly change of 14.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr2.40 Billion | -8.18% |
| 2025 | Skr2.61 Billion | +14.58% |
| 2024 | Skr2.28 Billion | +28.81% |
| 2023 | Skr1.77 Billion | +8.20% |
| 2022 | Skr1.64 Billion | -61.66% |
| 2021 | Skr4.27 Billion | +125.29% |
| 2020 | Skr1.90 Billion | +54.43% |
| 2019 | Skr1.23 Billion | +45.28% |
| 2018 | Skr844.88 Million | +15.57% |
| 2017 | Skr731.04 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Medicover AB Series B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.40 Billion USD |
| MoneyControl | $2.40 Billion USD |
| MarketWatch | $2.40 Billion USD |
| marketcap.company | $2.40 Billion USD |
| Reuters | $2.40 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.